ALTO INGREDIENTS ($ALTO) posted quarterly earnings results for Q4 2025 on Wednesday, March 4th. The company reported earnings of $0.19 per share, beating estimates of -$0.02 by $0.21. The company also reported revenue of $231,970,000, missing estimates of $239,526,600 by $-7,556,600.
Stock price change since market close: +26.93%
You can see Quiver Quantitative's $ALTO stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
ALTO INGREDIENTS Hedge Fund Activity
We have seen 57 institutional investors add shares of ALTO INGREDIENTS stock to their portfolio, and 28 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MARSHALL WACE, LLP added 1,154,138 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,323,917
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 1,066,267 shares (+inf%) to their portfolio in Q4 2025, for an estimated $3,070,848
- SUSQUEHANNA INTERNATIONAL GROUP, LLP added 1,014,795 shares (+2755.0%) to their portfolio in Q4 2025, for an estimated $2,922,609
- TWO SIGMA INVESTMENTS, LP added 803,088 shares (+2207.1%) to their portfolio in Q4 2025, for an estimated $2,312,893
- D. E. SHAW & CO., INC. removed 649,674 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $1,871,061
- JANE STREET GROUP, LLC added 594,597 shares (+312.9%) to their portfolio in Q4 2025, for an estimated $1,712,439
- GOLDMAN SACHS GROUP INC added 449,697 shares (+169.4%) to their portfolio in Q4 2025, for an estimated $1,295,127
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
